Micron expects fiscal Q1 revenue of $61.5B ±$1.5B as it raises fiscal 2027 CapEx plans amid tighter 2027-2028 supply-demand (NASDAQ:MU)October 1, 2026
Karyopharm signals $130M–$150M revenue target for 2026 with pivotal myelofibrosis data readout ahead (NASDAQ:KPTI) Finances February 13, 2026 Comply with us on Google for the most recent inventory informationComply with Looking for Alpha on Google for the most…
